Kalkine has a fully transformed New Avatar.

Last update at 2026-03-10T21:01:40.918590Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Reflecting On Healthcare Technology for Providers Stocks’ Q1 Earnings: Evolent Health (NYSE:EVH)
Thu 22 May 25, 03:34 AM1 Unpopular Stock that Deserves Some Love and 2 to Turn Down
Fri 16 May 25, 04:39 AMHealthcare Technology for Providers Stocks Q1 Earnings Review: Premier (NASDAQ:PINC) Shines
Wed 14 May 25, 03:32 AMPremier, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Fri 09 May 25, 11:02 AM1 Healthcare Stock with Competitive Advantages and 2 to Brush Off
Fri 09 May 25, 04:37 AMPremier Third Quarter 2025 Earnings: Beats Expectations
Wed 07 May 25, 11:14 AM| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | 250.00M | 326.90M | 250.64M | 383.69M | 368.14M |
| Minority interest | 0.14M | 2.45M | 17.06M | 161.82M | 174.96M |
| Net income | 175.03M | 265.87M | 287.52M | 291.13M | 334.68M |
| Selling general administrative | 611.03M | 601.13M | 572.70M | 670.59M | 662.46M |
| Selling and marketing expenses | -9.48100M | -24.24900M | -40.37400M | -210.73400M | 223.48M |
| Gross profit | 896.29M | 885.04M | 837.33M | 866.80M | 862.01M |
| Reconciled depreciation | 133.79M | 129.11M | 121.06M | 152.83M | 140.16M |
| Ebit | 264.47M | 260.07M | 256.92M | 373.62M | 368.51M |
| Ebitda | 398.26M | 403.04M | 411.02M | 521.76M | 515.36M |
| Depreciation and amortization | 133.79M | 142.97M | 154.10M | 148.14M | 146.84M |
| Non operating income net other | 7.91M | 66.83M | -6.27600M | 10.07M | -0.37500M |
| Operating income | 242.09M | 260.07M | 256.92M | 373.62M | 368.51M |
| Other operating expenses | 1094.00M | 1172.83M | 1464.23M | 925.97M | 849.12M |
| Interest expense | 14.47M | 11.14M | 11.96M | 11.31M | 2.47M |
| Tax provision | 75.11M | 58.58M | -53.94300M | 92.56M | 33.46M |
| Interest income | - | - | - | - | 3.19M |
| Net interest income | -14.47000M | -11.14200M | -11.96400M | -11.31300M | -2.47100M |
| Extraordinary items | - | - | - | - | -234.55000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 75.11M | 58.58M | -53.94300M | 92.56M | 33.46M |
| Total revenue | 1336.10M | 1432.90M | 1721.15M | 1299.59M | 1217.64M |
| Total operating expenses | 654.20M | 624.97M | 580.42M | 493.18M | 493.49M |
| Cost of revenue | 439.81M | 547.86M | 883.82M | 432.79M | 355.63M |
| Total other income expense net | 22.38M | 66.83M | -6.27600M | 10.07M | -0.37500M |
| Discontinued operations | - | - | - | 0.56M | -24.65000M |
| Net income from continuing ops | 174.89M | 268.32M | 304.58M | 291.13M | 334.68M |
| Net income applicable to common shares | 175.03M | 265.87M | 304.58M | 598.67M | -8.94400M |
| Preferred stock and other adjustments | - | - | 26.68M | -468.31100M | 118.06M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 3371.49M | 3357.13M | 3522.90M | 2948.51M | 2569.57M |
| Intangible assets | 430.03M | 356.57M | 396.64M | 417.42M | 270.72M |
| Earning assets | - | - | - | - | - |
| Other current assets | 60.39M | 325.64M | 68.05M | 97.34M | 27.15M |
| Total liab | 1037.13M | 1108.28M | 1293.01M | 2809.25M | 3431.82M |
| Total stockholder equity | 2334.36M | 2248.85M | 2229.89M | 139.26M | -862.25000M |
| Deferred long term liab | 27.91M | 23.79M | 23.18M | 20.74M | 19.54M |
| Other current liab | 420.57M | 427.18M | 423.07M | 326.23M | 340.25M |
| Common stock | 1.26M | 1.25M | 1.23M | 0.72M | 0.64M |
| Capital stock | 1.26M | 1.25M | 1.23M | 0.72M | 0.64M |
| Retained earnings | 405.10M | 331.69M | 169.47M | 0.00000M | -775.67400M |
| Other liab | 97.55M | 2603.99M | 527.79M | 2255.55M | 2967.79M |
| Good will | 1012.36M | 999.91M | 999.91M | 941.97M | 880.71M |
| Other assets | 814.09M | 886.62M | 918.35M | 572.88M | 499.35M |
| Cash | 89.79M | 86.14M | 129.14M | 99.30M | 141.06M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 815.46M | 753.14M | 716.78M | 496.07M | 458.02M |
| Current deferred revenue | 24.31M | 30.46M | 34.06M | 35.45M | 35.62M |
| Net debt | 350.54M | 401.14M | 392.53M | 37.89M | -107.44400M |
| Short term debt | 316.21M | 250.86M | 174.24M | 79.56M | 27.61M |
| Short long term debt | 316.21M | 250.86M | 174.24M | 79.56M | 27.61M |
| Short long term debt total | 440.33M | 487.29M | 521.67M | 137.19M | 33.61M |
| Other stockholder equity | 1928.01M | 1915.92M | 2059.19M | 138.55M | -87.22000M |
| Property plant equipment | 212.31M | 252.91M | 272.47M | 104.95M | 45.51M |
| Total current assets | 641.63M | 645.57M | 782.30M | 618.36M | 614.04M |
| Long term investments | 231.83M | 215.54M | 153.22M | 133.34M | 99.64M |
| Net tangible assets | 2334.36M | -1356.48500M | 833.34M | -1379.72400M | -2173.28100M |
| Short term investments | - | - | 153.22M | - | - |
| Net receivables | 414.51M | 374.19M | 408.73M | 350.72M | 394.81M |
| Long term debt | 102.26M | 2.28M | 304.33M | 4.64M | 6.00M |
| Inventory | 76.93M | 119.65M | 176.38M | 71.00M | 51.03M |
| Accounts payable | 54.38M | 44.63M | 85.41M | 54.84M | 54.54M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -0.00800M | -0.00300M | - | -452.60900M | -359.23500M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 1.26M | 1.25M | 1.23M | 0.72M | 0.64M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 405.10M | 331.69M | 169.47M | - | -775.67400M |
| Treasury stock | - | -250.12900M | - | - | -87.22000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 160.46M | 161.59M | 136.53M | 142.85M | 77.33M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2729.86M | 2711.56M | 2740.60M | 2330.15M | 1955.52M |
| Capital lease obligations | 21.86M | 32.96M | 43.10M | 52.99M | - |
| Long term debt total | 102.26M | 2.28M | - | 284.62M | 6.00M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -273.62200M | -16.00000M | -174.56800M | -10.16500M | -7.87600M |
| Change to liabilities | -19.59000M | -70.66900M | 134.08M | -30.35300M | 22.14M |
| Total cashflows from investing activities | -273.62200M | -139.44000M | -174.56800M | -222.32200M | -129.47000M |
| Net borrowings | -35.85900M | -24.24300M | -50.71300M | 47.58M | -75.67600M |
| Total cash from financing activities | -167.26600M | -347.78900M | -202.99700M | -168.95300M | -387.20000M |
| Change to operating activities | - | - | - | - | 18.90M |
| Net income | 174.89M | 268.32M | 304.58M | 291.13M | 334.68M |
| Change in cash | 3.65M | -42.99800M | 29.84M | -41.75100M | -11.33100M |
| Begin period cash flow | 86.14M | 129.14M | 99.30M | 141.06M | 152.39M |
| End period cash flow | 89.79M | 86.14M | 129.14M | 99.30M | 141.06M |
| Total cash from operating activities | 444.54M | 444.23M | 407.40M | 349.52M | 505.34M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 133.79M | 129.11M | 121.06M | 152.83M | 140.16M |
| Other cashflows from investing activities | -189.26000M | -36.00000M | -1.22900M | -117.76000M | -28.20900M |
| Dividends paid | -100.23300M | -96.45500M | -102.84700M | -48.90400M | 57.83M |
| Change to inventory | - | - | - | - | 1.60M |
| Change to account receivables | 64.25M | 124.66M | -68.00800M | -121.73500M | -6.69900M |
| Sale purchase of stock | 6.08M | -250.12900M | 0.00000M | -150.09300M | -258.26700M |
| Other cashflows from financing activities | 438.83M | 310.27M | 175.56M | -17.53700M | -17.71900M |
| Change to netincome | 132.29M | 40.04M | -15.56800M | 89.39M | 88.68M |
| Capital expenditures | 82.30M | 87.44M | 88.88M | 94.40M | 93.39M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | 23.16M | 77.44M | -119.69300M | -154.52400M | -31.33200M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | 3.65M | -42.99500M | 29.84M | -41.75100M | -11.33100M |
| Change in working capital | 3.58M | 6.77M | 14.39M | -160.29300M | -7.58400M |
| Stock based compensation | 13.73M | 46.23M | 35.42M | 20.71M | 29.00M |
| Other non cash items | 47.15M | -62.98300M | 15.64M | -22.82200M | -2.79700M |
| Free cash flow | 362.24M | 356.79M | 318.53M | 255.13M | 411.95M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PINC Premier Inc |
- -% | - | 27.90 | 9.28 | 1.92 | 1.06 | 1.77 | 6.22 |
| GEHC GE HealthCare Technologies Inc. |
-2.9 3.83% | 72.73 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-5.88 3.01% | 189.69 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 11.42 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.07 1.34% | 5.17 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.
13034 Ballantyne Corporate Place, Charlotte, NC, United States, 28277
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael J. Alkire | Pres, CEO & Director | 1963 |
| Mr. Craig Steven McKasson | Chief Admin. Officer, CFO, Sr. VP & Treasurer | 1967 |
| Mr. David L. Klatsky J.D. | Gen. Counsel | 1962 |
| Mr. Leigh T. Anderson | Pres of Performance Services | 1967 |
| Mr. David Alfred Hargraves | Sr. VP of Supply Chain | 1969 |
| Ms. Crystal Climer | Chief Accounting Officer | NA |
| Ms. Angeline C. McCabe | VP of Investor Relations | NA |
| Ms. Kaycee Kalpin | Chief Marketing Officer | NA |
| Ms. Susan Dodson DeVore | Advisor | 1959 |
| Mr. Andy Brailo | Chief Customer Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.